Modafinil
Abstract
Modafinil is a psychostimulant often used for treatment of sleep disorders such as narcolepsy. Although the exact mechanism of action of the drug is still unclear, several studies have suggested the involvement of dopamine and norepinephrine transporters. The cognitive-enhancing effects of Modafinil have been studied in both sleep-deprived and non-sleep-deprived individuals. Even if some findings were mixed, in general, results seem promising and Modafinil appears to enhance cognitive functions, especially attention and cognitive control. However, impairment of performance on certain tasks (such as creativity) and a detrimental overconfidence-effect have also been reported. In this chapter, we review if and under which conditions the administration of Modafinil might enhance cognition in both non-sleep-deprived and sleep-deprived healthy adults. In non-sleep-deprived adults, Modafinil appears to increase specifically attention and cognitive control and this effect seems to be more pronounced in challenging task conditions and in low performing individuals. In sleep-deprived adults, Modafinil seems to maintain and restore performance on cognitive tasks, but at the possible costs of subjective overconfidence. Although more research is necessary to completely understand the neurobiological underpinnings, Modafinil seems a promising tool for enhancing cognition considering its low abuse liability.
Keywords
Modafinil Adrafinil Eugeroic Dopamine Cognitive enhancer Cognition Memory Overconfidence-effect Sleep deprivation Maintenance studies Recuperation studiesReferences
- Ballon, J. S., & Feifel, D. (2006). A systematic review of Modafinil: Potential clinical uses and mechanisms of action. Journal of Clinical Psychiatry, 67(4), 554–566.CrossRefPubMedGoogle Scholar
- Baranski, J. V., Cian, C., Esquivié, D., Pideau, R. A., & Raphel, C. (1998). Modafinil during 64 h of sleep deprivation: Dose-related effects on fatigue, alertness, and cognitive performance. Military Psychology, 10(3), 173–193.CrossRefGoogle Scholar
- Baranski, J. V., Gil, V., McLellan, T., Moroz, D., Buguet, A., & Radomskir, M. (2002). Effects of Modafinil on cognitive performance during 40 hours of sleep deprivation in a warm environment. Military Psychology, 14, 23–48.CrossRefGoogle Scholar
- Baranski, J. V., & Pigeau, R. (1997). Self-monitoring cognitive performance during sleep deprivation: Effects of Modafinil, d-amphetamine and placebo. Journal of Sleep Research, 6, 84–91.CrossRefPubMedGoogle Scholar
- Baranski, J. V., Pigeau, R., Dinich, P., & Jacobs, I. (2004). Effects of Modafinil on cognitive and meta-cognitive performance. Human Psychopharmacology: Clinical and Experimental, 19, 323–332.CrossRefGoogle Scholar
- Batejat, D., & Lagarde, D. (1999). Naps and Modafinil as countermeasures for the effects of sleep deprivation on cognitive performance. Aviation, Space and Environmental Medicine, 70(5), 493–498.Google Scholar
- Bodenmann, S., Xu, S., Luhmann, U. F. O., Arand, M., Berger, W., Jung, H. H., et al. (2009). Pharmacogenetics of Modafinil after sleep loss: Catechol-O-methyltransferase genotype modulates waking functions but not recovery sleep. Clinical Pharmacology and Therapeutics, 85(3), 296–304.CrossRefPubMedGoogle Scholar
- Caldwell, J. A., Jr., Caldwell, J. L., Smyth, N. K., III, & Hall, K. K. (2000). A double-blind, placebo-controlled investigation of the efficacy of modafinil for sustaining the alertness and performance of aviators: A helicopter simulator study. Psychopharmacology (Berl), 150(3), 272–282.CrossRefGoogle Scholar
- Dunn, D., Hostetler, G., Iqbal, M., Messina-McLaughlin, P., Reiboldt, A., Lin, Y. G.,… & Chatterjee, S. (2012). Wake-promoting agents: Search for next generation Modafinil: Part I. Bioorganic & Medicinal Chemistry Letters, 22, 2312–2314.Google Scholar
- Fontan, B., Fontarai, J., Micas, M., & Albarede, J. L. (1990). Value of computerized psychometric evaluation in the assessment of the activity of Olmifon (adrafinil) on alertness and cognitive performance in elderly retirement home patients. Psychologie Medicale, 22, 253–267.Google Scholar
- Franke, A. G., Bagusat, C., Dietz, P., Hoffmann, I., Simon, P., Ulrich, R., et al. (2013). Use of illicit and prescription drugs for cognitive or mood enhancement among surgeons. BMC Medicine, 11(1), 1.CrossRefGoogle Scholar
- Funayama, T., Ikeda, Y., Tateno, A., Takahashi, H., Okubo, Y., Fukayama, H., et al. (2014). Modafinil augments brain activation associated with reward anticipation in the nucleus accumbens. Psychopharmacology (Berl), 231, 3217–3228.CrossRefGoogle Scholar
- Geng, J. J., Soosman, S., Sun, Y., DiQuattro, N. E., Stankevitch, B., & Minzenberg, M. J. (2013). A match made by Modafinil: Probability matching in choice decisions and spatial attention. Journal of Cognitive Neuroscience, 25(5), 657–669.CrossRefPubMedGoogle Scholar
- Greely, H., Sahakian, B., Harris, J., Kessler, R. C., Gazzaniga, M., Campbell, P., et al. (2008). Towards responsible use of cognitive-enhancing drugs by the healthy. Nature, 456(7223), 702–705.CrossRefPubMedGoogle Scholar
- Gurtman, C. G., Broadbear, J. H., & Redman, J. R. (2008). Effects of Modafinil on simulator driving and self-assessment of driving following sleep deprivation. Human Psychopharmacology: Clinical and Experimental, 23, 681–692.CrossRefGoogle Scholar
- Jasinski, D. R. (2000). An evaluation of the abuse potential of Modafinil using methylphenidate as a reference. Journal of Psychopharmacology, 14(1), 53–60.CrossRefPubMedGoogle Scholar
- Keating, G. M., & Raffin, M. J. (2005). Modafinil. CNS Drugs, 19(9), 785–803.CrossRefPubMedGoogle Scholar
- Kollins, S. H., MacDonald, E. K., & Rush, C. R. (2001). Assessing the abuse potential of methylphenidate in nonhumans and human subjects: A review. Pharmacology, Biochemistry and Behavior, 68, 611–627.CrossRefPubMedGoogle Scholar
- Lagarde, D., & Batejat, D. (1995). Some measures to reduce effects of prolonged sleep deprivation. Clinical Neurophysiology, 25(6), 376–385.CrossRefPubMedGoogle Scholar
- Louvet, P., Schweizer, D., Gourdel, M., Riguet, E., Yue, C., Marcy, V. R.,… & Chatterjee, S. (2012). Wake-promoting agents: Search for next generation Modafinil: Part IV. European Journal of Medicinal Chemistry, 54, 949–951.Google Scholar
- Madras, B. K., Xie, Z., Lin, Z., Jassen, A., Panas, H., Lynch, L.,… Fischman, A. J. (2006). Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro. The Journal of Pharmacology and Experimental Therapeutics, 319(2), 561–569.Google Scholar
- Marchant, N. L., Kamel, F., Echlin, K., Grice, J., Lewis, M., & Rusted, J. M. (2009). Modafinil improves rapid shifts of attention. Psychopharmacology (Berl), 202, 487–495.CrossRefGoogle Scholar
- McClellan, K. J., & Spencer, C. M. (1998). Modafinil. CNS Drugs, 9(4), 311–324.CrossRefPubMedGoogle Scholar
- Mereu, M., Bonci, A., Newman, A. H., & Tanda, G. (2013). The neurobiology of Modafinil as an enhancer of cognitive performance and a potential treatment for substance use disorders. Psychopharmacology (Berl), 229(3), 415–434.CrossRefGoogle Scholar
- Minzenberg, M. J., & Carter, C. S. (2008). Modafinil: A review of neurochemical actions and effects on cognition. Neuropsychopharmacology, 33, 1477–1502.CrossRefPubMedGoogle Scholar
- Moachon, G., Kanmacher, I., Clenet, M., & Matinier, D. (1996). Pharmacokinetic profile of Modafinil. Drugs Today, 32, 327–337.Google Scholar
- Mohamed, A. D. (2014). The effects of Modafinil on convergent and divergent thinking of creativity: A randomized controlled trial. Journal of Creative Behavior. Available at: http://dx.doi.org/10.1002/jocb.1073 (Online ahead of publication)
- Mohamed, A. D. (2015). The effects of Modafinil on motivation and salience of pleasure in healthy individuals: Quantitative evidence from the cognitive neurosciences. AJOB Neuroscience, 6(1), 15–17.CrossRefGoogle Scholar
- Müller, U., Rowe, J. B., Rittman, T., Lewis, C., Robbins, T. W., & Sahakian, B. K. (2013). Effects of Modafinil on non-verbal cognition, task enjoyment and creative thinking in healthy volunteers. Neuropharmacology, 64, 490–495.CrossRefPubMedPubMedCentralGoogle Scholar
- Müller, U., Steffenhagen, N., Regenthal, R., & Bublak, P. (2004). Effects of Modafinil on working memory processes in humans. Psychopharmacology (Berl), 177(1–2), 161–169.CrossRefGoogle Scholar
- Pigeau, R., Naitoh, P., Buguet, A., McCann, C., Baranski, J., Taylor, M.,… & Mack, I. (1995). Modafinil, d‐amphetamine and placebo during 64 hours of sustained mental work. I. Effects on mood, fatigue, cognitive performance and body temperature. Journal of Sleep Research, 4(4), 212–228.Google Scholar
- Randall, D. C., Shneerson, J. M., & File, S. E. (2005). Cognitive effects of Modafinil in student volunteers may depend on IQ. Pharmacology, Biochemistry and Behavior, 82(1), 133–139.CrossRefPubMedGoogle Scholar
- Stivalet, P., Esquivié, D., Barraud, P., Leifflen, D., & Raphel, C. (1998). Effects of Modafinil on attentional processes during 60 hours of sleep deprivation. Human Psychopharmacology, 13(7), 501–507.CrossRefGoogle Scholar
- Turner, D. C., Robbins, T. W., Clark, L., Aron, A. R., Dowson, J., & Sahakian, B. J. (2003). Cognitive enhancing effects of Modafinil in healthy volunteers. Psychopharmacology (Berl), 165, 260–269.CrossRefGoogle Scholar
- Whitmore, J., Doan, B., Fischer, J., French, J., & Heintz, T. (2004). The efficacy of Modafinil as an operational fatigue countermeasure over several days of reduced sleep during a simulated escape and evasion scenario (No. AFRL-HE-BR-TR-2002–0021). Air force research lab brooks AFB TX human effectiveness DIR/biodynamics and protection DIV.Google Scholar
- Whitmore, J., Hickey, P., Doan, B., Harrison, R., Kisner, J., Beltran, T.,… & Marks, F. (2006). A double-blind placebo-controlled investigation of the efficacy of Modafinil for maintaining alertness and performance in sustained military ground operations. AIR FORCE RESEARCH LAB BROOKS AFB TX HUMAN EFFECTIVENESS DIR/BIODYNAMICS AND PROTECTION DIV.Google Scholar